![bpc-157 human clinical trials randomized double blind Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] The Stable Gastric Pentadecapeptide BPC](https://www.preprints.org/frontend/picture/ms_xml/manuscript/ae34a89ce81cb490bff0445a6ef28159/preprints-206876-g004.png)
bpc-157 human clinical trials randomized double blind Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] The Stable Gastric Pentadecapeptide BPC
Description
There are various functional autoantibodies in patients with systemic sclerosis secreted by dysregulated B cells that target endothelial cells, intercellular adhesion molecule 1 (ICAM-1), endothelin type A receptor (ETAR), angiotensin II type I receptor (AT1R) and platelet-derived growth factor receptor (PDGFR)
![bpc-157 human clinical trials randomized double blind Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] The Stable Gastric Pentadecapeptide BPC](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cee/11053547/a0d24268bf32/pharmaceuticals-17-00461-g002.jpg)
And it was bothering me so much
![bpc-157 human clinical trials randomized double blind Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] The Stable Gastric Pentadecapeptide BPC](https://cdn.prod.website-files.com/67dad572c1161755c83f54f7/6a51ef03c952a31019434b4d_69f16d27b29e39495355b19e_xYceohHJrNtYcUUr.webp)
[DOI] [PubMed] [Google Scholar] 51.Zhai D., Ye Z., Jiang Y., Xu C., Ruan B., Yang Y., Lei X., Xiang A., Lu H., Zhu Z., et al
![bpc-157 human clinical trials randomized double blind Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] The Stable Gastric Pentadecapeptide BPC](https://www.frontiersin.org/files/Articles/718147/xml-images/fphar-12-718147-g001.webp)
Marketed as a fatburning peptide, AOD9604 claims to accelerate fat breakdown, improve metabolic flexibility, and support body recomposition
![bpc-157 human clinical trials randomized double blind Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] The Stable Gastric Pentadecapeptide BPC](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a76f/10385428/47f8a6611cda/pharmaceuticals-16-01052-g008.jpg)
